ANIP
ANI Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$70.49
-2.00 ▼ -2.76%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$70.49
+0.00 +0.00%
| Index | RUT | P/E | 21.03 | EPS (ttm) | 3.35 | Insider Own | 12.58% | Shs Outstand | 0.02B | Perf Week | -4.79% |
| Market Cap | 1.58B | Forward P/E | 6.78 | EPS next Y | 13.82% | Insider Trans | -2.86% | Shs Float | 0.02B | Perf Month | -7.55% |
| Enterprise Value | 1.91B | PEG | 0.45 | EPS next Q | 1.5 | Inst Own | 95.91% | Short Float | 18% | Perf Quarter | -14.07% |
| Income | 0.07B | P/S | 1.79 | EPS this Y | 15.72% | Inst Trans | 3.96% | Short Ratio | 7.81 | Perf Half Y | -28.6% |
| Sales | 0.88B | P/B | 2.93 | EPS next 5Y | 15.03% | ROA | 5.24% | Short Interest | 3.53M | Perf YTD | -10.7% |
| Book/sh | 24.03 | P/C | 5.36 | EPS past 3/5Y | - | ROE | 15.11% | 52W High | -29.16% ($99.50) | Perf Year | 14.7% |
| Cash/sh | 13.14 | P/FCF | 9.22 | Sales past 3/5Y | 40.81% 33.48% | ROIC | 6.11% | 52W Low | 24.3% ($56.71) | Perf 3Y | 71.88% |
| Dividend Est. | $1.4 (1.99%) | EV/EBITDA | 11.09 | EPS Y/Y TTM | 411.46% | Gross Margin | 51.01% | Volatility(W/M) | 4.09% 3.64% | Perf 5Y | 117.97% |
| Dividend TTM | - | EV/Sales | 2.17 | Sales Y/Y TTM | 43.78% | Oper. Margin | 9.2% | ATR (14) | 2.85 | Perf 10Y | 94.94% |
| Dividend Ex-Date | - | Quick Ratio | 2.19 | EPS Q/Q | 313.31% | Profit Margin | 7.95% | RSI (14) | 33.12 | Recom | 1.38 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.71 | Sales Q/Q | 29.64% | SMA20 | -7.04% ($75.83) | Beta | 0.47 | Target Price | $110.62 |
| Payout | - | Debt/Eq | 1.16 | Earnings | 2000000 | SMA50 | -10.8% ($79.02) | Rel Volume | 1.15 | Prev Close | $72.49 |
| Employees | 970 | LT Debt/Eq | 1.13 | EPS/Sales Surpr. | 16.99% 6.91% | SMA200 | -12.33% ($80.4) | Avg Volume(3M) | 0.45M | Price | $70.49 |
| IPO | 2000/5/12 | Option/Short | Yes/Yes | Trades | 7279 | Volume | 517,922 | Change | -2.76% |
뉴스 로딩 중...